ocular inflammation uveitis
Conditions
Interventions
None listed
Sponsors
Universitair Medisch Centrum Utrecht
Eligibility
Age
No minimum to 99 Years
Inclusion criteria
Inclusion criteria: Patients aged under 96 years old diagnosed with ocular inflammation: - uveitis; anterior uveitis, intermediate uveitis, panuveitis, scleritis and posterior uveitis - inflammatory corneal disease (keratokonus or Fuchs endothelial corneal dystrophy) - inflammatory orbital disease and orbital lymphoma - Age-related macular degeneration - Retinal dystrophy - Multifocal choroidal retinitis - Strabismus
Exclusion criteria
Exclusion criteria: - Patients with acquired immune deficiencies will not be eligible for participation. - Patients who do not speak or understand the Dutch language adequately will also be excluded from participation in this study - Current effective use of systemic immunomodulatory agents (antimetabolites), biologicals or cyclosporine. -IV corticosteroids in the last 14 days for inclusion -Age >=96 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the networks acquisition of high throughput analyses of distinct layers (e.g. mRNA, microRNA, methylation status, proteome) and various cellular subsets (e.g. B cells, T cells, dendritic cells, NK cells) | — |
Countries
Netherlands
Outcome results
None listed